Terazosin Capsule
Product Images NDC 62135-460

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 62135-460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Terazosin Cap Usp 10mg 90 Bot Lab)

Terazosin Capsules, USP 10 mg oral capsules packaging label by Chartwell RX, LLC. The label shows NDC 62135-461-90 and indicates the product contains 90 capsules. It includes dosage information, storage instructions, and safety warnings such as protecting the capsules from light and moisture. The label features a barcode and a note that the product is Rx only.*

FDA Label Image

Image Description (Terazosin Cap Usp 1mg 90 Bot Lab)

Terazosin capsules, USP 1 mg in a package of 90 capsules. The label includes storage instructions, dosage information, and warnings to protect from light and moisture. The labeler is Chartwell RX, LLC, and the NDC is 62135-458-90. Packaging is primarily white with blue and orange accents.*

FDA Label Image

Image Description (Terazosin Cap Usp 2mg 90 Bot Lab)

Terazosin Capsules, USP 2 mg oral capsules label from Chartwell RX, LLC. The package contains 90 capsules and is marked Rx Only. It includes storage and handling instructions to protect from light and moisture, patient information reference, and a barcode. The label highlights the 2 mg strength in a red box.*

FDA Label Image

Image Description (Terazosin Cap Usp 5mg 90 Bot Lab)

Terazosin Capsules, USP 5 mg oral capsules packaging label. The label indicates prescription use only with a quantity of 90 capsules. It features the Chartwell RX, LLC labeler name and includes storage instructions along with warnings to protect from light and moisture. The label also displays the NDC number 62135-460-90 and a barcode.*

FDA Label Image

Image Description (Terazosin Cap Usp Fig 1)

Figure 1 from Study 1 presenting two line graphs comparing Terazosin versus placebo over 3 months. The left graph shows mean change in total symptom score from baseline, with Terazosin showing a greater decrease than placebo. The right graph shows mean increase in peak flow rate (mL/sec) from baseline, with Terazosin showing a greater increase compared to placebo. Data points include sample sizes (N) and statistical significance indicated.*

FDA Label Image

Image Description (Terazosin Cap Usp Fig 2)

Figure 2 is a line graph displaying the mean change in total symptom score from baseline over 30 months in a long-term, open-label, non-placebo controlled study with 494 subjects. The y-axis shows mean change from baseline, while the x-axis represents months. Data points show a decrease in symptoms, with several statistically significant reductions noted.*

FDA Label Image

Image Description (Terazosin Cap Usp Fig 3)

A line graph titled 'Mean Change in Peak Flow Rate from Baseline' from a long-term, open-label, non-placebo controlled study with 494 participants. The graph shows mean change from baseline (mL/sec) on the vertical axis over months on the horizontal axis, with data points marked and error bars indicating variability. Statistically significant changes versus baseline are noted with asterisks (*). Mean baseline is reported as 9.9.*

FDA Label Image

Image Description (Terazosin Cap Usp Structure)

Chemical structure of Terazosin hydrochloride dihydrate showing its molecular formula (C19H25N5O4 · HCl) and molecular weight (459.93). The diagram includes aromatic rings, nitrogen atoms, and functional groups characteristic of Terazosin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.